ACICLOVIR VIATRIS aciclovir (as sodium) 250 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

aciclovir viatris aciclovir (as sodium) 250 mg powder for injection vial

alphapharm pty ltd - aciclovir sodium dihydrate, quantity: 314.4 mg (equivalent: aciclovir, qty 250 mg) - injection, powder for - excipient ingredients: - aciclovir mylan (aciclovir sodium) is indicated for:,- promoting resolution of acute clinical manifestations of mucocutaneous herpes simplex virus infections in immunocompromised patients,- treatment of severe first episode primary or non-primary genital herpes in immune competent patients,- treatment of acute manifestations of varicella zoster virus infection in immunocompromised patients,- treatment of herpes zoster (shingles) in immune competent patients who show very severe acute local or systemic manifestations of the disease. (benefits can be expected in patients with rash duration shorter than 72 hours. the use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients with shingles).,- treatment of herpes simplex encephalitis.

ACICLOVIR VIATRIS aciclovir (as sodium) 500 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

aciclovir viatris aciclovir (as sodium) 500 mg powder for injection vial

alphapharm pty ltd - aciclovir sodium dihydrate, quantity: 628.8 mg (equivalent: aciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - aciclovir mylan (aciclovir sodium) is indicated for:,- promoting resolution of acute clinical manifestations of mucocutaneous herpes simplex virus infections in immunocompromised patients,- treatment of severe first episode primary or non-primary genital herpes in immune competent patients,- treatment of acute manifestations of varicella zoster virus infection in immunocompromised patients,- treatment of herpes zoster (shingles) in immune competent patients who show very severe acute local or systemic manifestations of the disease. (benefits can be expected in patients with rash duration shorter than 72 hours. the use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients with shingles).,- treatment of herpes simplex encephalitis.

Valaciclovir Bluefish 500 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

valaciclovir bluefish 500 mg film-coated tablets

bluefish pharmaceuticals ab - valaciclovir - film-coated tablet - 500 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valaciclovir

Valaciclovir 500mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valaciclovir 500mg tablets

a a h pharmaceuticals ltd - valaciclovir hydrochloride - oral tablet - 500mg

Valaciclovir 500mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valaciclovir 500mg tablets

phoenix healthcare distribution ltd - valaciclovir hydrochloride - oral tablet - 500mg

Valaciclovir 500mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valaciclovir 500mg tablets

sigma pharmaceuticals plc - valaciclovir hydrochloride - oral tablet - 500mg